AMICUS THERAPEUTICS, INC. (FOLD)

Amicus Therapeutics, Inc. operates as a biotechnology company. The firm focuses on discovering, developing and delivering medicines for people living with metabolic diseases. Its product portfolio includes first and only approved oral precision medicine for people living with Fabry disease who have amenable genetic variants, a novel, clinical-stage, treatment paradigm for Pompe disease and a rare disease gene therapy portfolio. The company was founded by John Francis Crowley on February 4, 2002 and is headquartered in Princeton, NJ.

Address

3675 MARKET STREET
PHILADELPHIA, PA 19104

Founded

2002

Number of Employees

517

Website

http://www.amicusrx.com

Buyback

Buyback Data 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 Average
$ Amount Purchased
($ in 000s)		 - $3,726 $920 - - - $2,324 $15,193 $11,606 $17,738 $16,436 $9,706
Average Price - $10.81 $8.24 - - - $14.68 $21.11 $11.30 $12.10 $13.22 $13.40
# Shares Purchased - 344,698 111,688 - - - 158,277 719,832 1,026,958 1,465,960 1,243,352 724,395
Buyback Performance 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 Average
Total Return to Date - 1.8% 33.5% - - - -25.1% -47.9% -2.7% -9.1% -16.8% -17.9%
S&P 500 Return to Date - 173.0% 168.6% - - - 74.8% 31.7% 37.3% 31.3% 7.4% 74.9%
Excess Total Return - -171.2% -135.1% - - - -99.9% -79.5% -39.9% -40.4% -24.2% -92.8%
Quartile Rank
Percentile Rank - 33% 42% - - - 17% 15% 43% 28% 17% 29%
Buyback returns calculated using weighted average buyback price over the last 10 years and comparing to current day stock price value. S&P 500 used as benchmark for excess return.

Insider Transactions

Filters

Keyboard Shortcuts: Show (a) | Close (Esc)

People also followed
Day One Biopharmaceuticals, Inc.
Blueprint Medicines Corp
CASTELLI JEFF

AMICUS THERAPEUTICS, INC.
PERCEPTIVE ADVISORS LLC

ANI PHARMACEUTICALS INC